Psychosocial and Behavioral Intervention for Stem Cell Transplant Patients and Their Family Caregivers
Adapting After Discharge From Allogeneic SCT: Partnering Together; Dyadic Intervention to Improve Patient-Family Caregiver Team-Based Management of the Medical Regimen After Allogeneic Hematopoietic Cell Transplantation
University of Pittsburgh
208 participants
Jul 1, 2025
INTERVENTIONAL
Conditions
Summary
Adherence to the medical regimen after stem cell transplant is challenging for both patients and their family caregivers. The investigators propose a randomized clinical trial testing two brief psychosocial interventions to determine if either improves patient and family caregiver psychosocial and health-related outcomes.
Eligibility
Inclusion Criteria4
- Patient undergoing a stem cell transplant at the University of Pittsburgh Hillman Cancer Center
- years or older
- having a family caregiver age 18 years or older also willing to participate in the study
- willing to accept randomization
Exclusion Criteria2
- Prior history of stem cell transplant
- Non-English speaking
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DPST consists of teaching the patient and family caregiver problem-solving skills that they can apply to help them manage the medical regimen after stem cell transplant.
Supportive Care consists of providing support to the patient and family caregiver as they manage the medical regimen after stem cell transplant
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07107165